The Canadian Journal of Urology: CJU
ISSN: 1195-9479 (Print)
ISSN: 1488-5581 (Online)
Aims & Scope
The Canadian Journal of Urology (CJU) is a peer reviewed indexed journal published bi-monthly (6 issues per year), We welcome the urological medical community to submit original research articles, review articles, practice updates and case reports. Topics of interests include but are not limited to:
■ Urinary System Neoplasms
■ Prostatic Disorders
■ Urolithiasis
■ Male Genitourinary Health
■ Urinary Tract Reconstruction Surgery
■ Minimally Invasive Surgical Techniques
Publication Frequency
Bi-monthly
IF
Current Impact Factor: 0.9 (2024)
5-Year Impact Factor: 1.5
Citescore
1.8 (2024)
Acceptance rate
24% (2025 1st quarter)
Speed
Submission to first post-review decision (average time): 31 days (2025 1st quarter)
Submission to acceptance (average time): 72 days (2025 1st quarter)
Ownership
The journal is owned by Tech Science Press.
Open Access
The Canadian Journal of Urology (CJU) transitioned to a fully Open Access journal in 2025. All articles published from 2025 onward will be Gold Open Access under the Creative Commons Attribution License 4.0 (CC-BY 4.0), and are made freely and permanently accessible online from the date of publication. For further information, please refer to TSP’s Open Access Policy.
Previously published content prior to 2025 is now free to read on the journal platform. These backfile articles remain under their original copyright and licensing terms (all rights reserved unless otherwise stated on the article/PDF). For further information, please refer to TSP’s Copyright and Licensing Policy.
Ethics Statement
TSP takes the responsibility to enforce a rigorous peer-review together with strict ethical policies and standards to ensure adding the highest quality scientific works to the field of scholarly publication. TSP takes such publishing ethics issues very seriously on every level. Our staff are trained to identify and report any irregularities. Our editors follow Guidelines of the Committee on Publication Ethics (COPE), and proceed with a zero tolerance policy for ethical violations, including plagiarism, data falsification and authorship misconduct. To confirm the originality of all submitted manuscripts, we use iThenticate for similarity checks against prior publications.